List of Small Molecule Pharmaceuticals Companies in Kansas - 4

cGMP Validation was established in 1997 as a full service validation/compliance firm offering services for the pharmaceutical, bulk pharmaceutical, animal health, biotechnology, biologics, medical device and medical diagnostic industries. Our team is comprised of a group of professionals with considerable experience within the pharmaceutical industry. Educational disciplines consist of chemistry, microbiology, engineering, pharmacy and computer science. Team expertise was not only developed through working with operating companies giving them a unique ability to coordinate with client personnel to assure that all facets of the project start-up and validation are considered. Many of our project leaders have been middle to senior level Quality Assurance Managers, Production Managers or Facility Managers thus having an excellent understanding of industry standards and FDA expectations. Successful projects have been performed throughout North America as well as Internationally. Clients range in size from small to large for pharmaceutical (finished and bulk), biological, medical device and diagnostic manufacturers. cGMP prides itself on all projects regardless of size, being given the same professional attention and management.

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.

For centuries, the desire to end human suffering inflicted by disease has sparked compassion, curiosity, and decades of research and drug development. It has pushed a relentless pursuit for answers, inspired bold thinking, and driven an unfaltering will to prevail in the face of daunting odds. While answers don't come easily, Genzada Pharmaceuticals is driven by hope and something more—remarkable science. We're proud to be part of a global community of physicians, scientists, chemists, clinicians, pharmaceutical experts, and like-minded pioneers working on the frontier of drug development. Together, we work to create treatments that will turn the tide against some of the deadliest forms of cancer. Our mission is rooted in an inventive mindset that fosters ground-breaking drug development. Our discoveries are the result of painstaking scientific rigor. Our novel therapeutics stem from natural compounds that boast extraordinary efficacy when precisely formulated to disrupt cancer development and progression. These discoveries may one day change patients' lives—and the world.

KCAS Bio is a top-tier contract research organization (CRO) that has 45 years of experience with both large pharma and biotech sponsors, providing comprehensive bioanalytical drug development services from early discovery through registration. We have supported more than 300+ FDA approved drugs on the market, developed 5,000+ proprietary and non-proprietary assays to date, and undergone 18 FDA audits with no major findings. Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve sponsors globally with bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management. With the expertise, capacity and flexibility sponsors require, we can fulfill our purpose, which is: to help accelerate the discovery and development of life-changing drugs smoothly, safely and sustainably.